Figure 2From: MRI characterization of uterine fibroids may predict success of GnRH agonist therapy prior to magnetic resonance focused ultrasound (MRgFUS) treatmentSagittal T2-weighted image following 3 months of GnRH agonist therapy, showing a 281 cc fibroid representing a 40% reduction in volume.Back to article page